Nasdaq Compliance. The Common Stock is registered pursuant to Section 12(g) of the Exchange Act, and is listed on The NASDAQ National Market (the "NASDAQ Stock Market"), and trading in the Common Stock has not been suspended and the Company has taken no action designed to, or that is likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the NASDAQ Stock Market. To the best of the Company's knowledge, the Company and the Common Stock meet the criteria for continued listing and trading on the NASDAQ Stock Market.
Appears in 2 contracts
Samples: Securities Purchase Agreement (Neurogen Corp), Securities Purchase Agreement (Warburg Pincus Private Equity Viii L P)
Nasdaq Compliance. The Common Stock is registered pursuant to Section 12(g) of the Exchange Act, Act and is listed on The the NASDAQ National Market (the "NASDAQ Stock Market"), and trading in the Common Stock has not been suspended and the Company has taken no action designed to, or that is likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the NASDAQ Stock Market. To the best of the Company's knowledge, the Company and the Common Stock meet the criteria for continued listing and trading on the NASDAQ Stock National Market.
Appears in 2 contracts
Samples: Registration Rights Agreement (Amgen Inc), Stock Purchase Agreement (Tularik Inc)
Nasdaq Compliance. The Common Stock is registered pursuant to Section 12(g12(b) of the Exchange Act, Act and is listed on The the NASDAQ National Market (the "NASDAQ Stock Global Market"), and trading in the Common Stock has not been suspended and the Company has taken no action designed to, or that is likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the NASDAQ Stock Market. To the best of the Company's knowledge, the Company and the Common Stock meet the criteria for continued listing and trading on the NASDAQ Stock Global Market.
Appears in 2 contracts
Samples: Collaboration and License Agreement (Facet Biotech Corp), Collaboration and License Agreement (Trubion Pharmaceuticals, Inc)
Nasdaq Compliance. The Common Stock is registered pursuant to Section 12(g12(b) of the Exchange Act, Act and is listed on The NASDAQ National Market (the "NASDAQ Stock Market")NASDAQ, and trading in the Common Stock has not been suspended and the Company has taken no action designed to, or that is likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting de-listing the Common Stock from NASDAQ, nor has the NASDAQ Stock Market. To Company received any notification that the best of the Company's knowledgeSEC, the Financial Industry Regulatory Authority or NASDAQ is contemplating terminating such registration or listing. The Company and the Common Stock meet the criteria for continued listing and trading on the NASDAQ Stock Market.is in
Appears in 1 contract
Samples: Securities Purchase Agreement (Alexza Pharmaceuticals Inc.)
Nasdaq Compliance. The Common Stock is registered pursuant to Section 12(g12(b) of the Exchange Act, Act and is listed on The NASDAQ National Market (the "NASDAQ Stock Market")NASDAQ, and trading in the Common Stock has not been suspended and the Company has taken no action designed to, or that is likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting de-listing the Common Stock from NASDAQ, nor has the NASDAQ Stock Market. To Company received any notification that the best of the Company's knowledgeSEC, the Company and the Common Stock meet the criteria for continued listing and trading on the Financial Industry Regulatory Authority or NASDAQ Stock Marketis contemplating terminating such registration or listing.
Appears in 1 contract
Samples: Securities Purchase Agreement (U.S. Auto Parts Network, Inc.)
Nasdaq Compliance. The Common Stock is registered pursuant to Section 12(g12(b) of the Exchange Act, Act and is listed on The NASDAQ National Market (the "NASDAQ Stock Nasdaq Global Select Market"), and trading in the Common Stock has not been suspended and the Company has taken no action designed to, or that is likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the NASDAQ Stock Market. To the best of the Company's knowledge, the Company and the Common Stock meet the criteria for continued listing and trading on the NASDAQ Stock The Nasdaq Global Select Market.
Appears in 1 contract
Samples: Stock Purchase Agreement (Clean Energy Fuels Corp.)
Nasdaq Compliance. The Common Stock is registered pursuant to Section 12(g) of the Exchange Act, Act and is listed on The NASDAQ National Market (the "NASDAQ Stock Market")NASDAQ, and trading in the Common Stock has not been suspended and the Company has taken no action designed to, or that is likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting de-listing the Common Stock from the NASDAQ Stock Market. To NASDAQ, nor has the best of Company received any notification that the Company's knowledgeSEC, the Company and the Common Stock meet the criteria for continued listing and trading on Financial Industry Regulatory Authority or the NASDAQ Stock Marketis contemplating terminating such registration or listing.
Appears in 1 contract
Samples: Securities Purchase Agreement (Metabasis Therapeutics Inc)
